Reddy's Laboratories gets USFDA nod for generic version of Suboxone
New Delhi: Dr Reddy's Laboratories has received final approval from the US health regulator for generic version of Suboxone, prescribed for opioid addiction.
"The product approved by the US Food and Drug Administration (USFDA) is a therapeutic equivalent generic version of Suboxone (buprenorphine and naloxone) sublingual film," Dr Reddy's Laboratories said in a BSE filing.
The company, which is launching the product in the US, said approval has been granted in the strengths of 2 mg/0.5 mg, 4 mg/1 mg, 8 mg/2 mg, and 12 mg/3 mg.
"Buprenorphine helps suppress withdrawal symptoms caused by discontinuation of opioid drugs, and naloxone reverses and blocks the effect of opioids. This combination of medications is used as part of a complete treatment program including prescription monitoring, counseling, and psychosocial support," Dr Reddy's Laboratories said.
The Suboxone brand had US sales of approximately USD 1.86 billion for the twelve months ending in April 2018, DRL said citing IMS Health data.
Shares of DRL were trading at Rs 2,348.50 apiece in the morning trade, up 3.53 per cent, on the BSE.
BSEbuprenorphineDr Reddy'sDRLnaloxoneopioid drugsSuboxoneUS Food and Drug AdministrationUS health regulatorUSFDA
Source : PTIMedical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here
Next Story
NO DATA FOUND
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd